Company Overview of Immunovative Therapies Ltd.
Key Executives for Immunovative Therapies Ltd.
|Michael Har-Noy||No Relationships||Founder and Chief Executive Officer||--|
|Antonio Treminio||10 Relationships||Chairman of Immunovative Inc and Chief Executive Officer of Immunovative Inc||47|
|Emmanuel Katsanis M.D.||9 Relationships||Chairman of the Scientific Advisory Board, Chief Medical Officer and Medical Monitor||--|
|Zivile Katiliene||No Relationships||Director of Regulatory Affairs and Clinical Operations||--|
Immunovative Therapies Ltd. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Ronald W. Hart Ph.D.||54 Relationships||Zuma360 Software, Inc.||75|
|Emmanuel Katsanis M.D.||9 Relationships||Immunovative Therapies Ltd.||--|
|Antonio Treminio||10 Relationships||Immunovative Therapies Ltd.||47|
|Malcolm R. Currie Ph.D.||88 Relationships||Greystone Digital Technologies, Inc.||89|
|Laurence Terrisse-Rulleau Ph.D.||38 Relationships||CTI Life Sciences||--|
Immunovative Therapies Ltd. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D.||Emmanuel Katsanis||9 Relationships||7 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.